DYN May 2024 25.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:55PM EDT. Market open.
| Previous close | 2.1000 |
| Open | 2.1000 |
| Bid | 0.0000 |
| Ask | 2.0000 |
| Strike | 25.00 |
| Expiry date | 2024-05-17 |
| Day's range | 2.1000 - 2.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | 23 |
Simply Wall St.We're Hopeful That Dyne Therapeutics (NASDAQ:DYN) Will Use Its Cash Wisely
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
- GuruFocus.com
Dyne Therapeutics Inc (DYN) Q1 2024 Earnings: Aligns with Analyst Projections
Overview of Financial Performance and Future Prospects
GlobeNewswireDyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
- Additional Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Anticipated in the Second Half of 2024 - WALTHAM, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today reported financial results for the first quarter of 2024 and recent business highlights. “I am excited about
© 2024 Yahoo. All rights reserved.